TechNation Radio Podcast

On this week’s Tech Nation, Moira speaks with … DR PEDRO DOMINGOS, a computer science professor from the University of Washington, tells us what google knows and what Twitter holds back.

Then on BioTech Nation, Stem Cells, Inc. makes a breakthrough treating cervical spinal cord injury with neural stem cells.

On this week’s Tech Nation, Moira speaks with Dr. Jon Patrick, CEO of HLA-Global, about “dark text” – all those pieces of paper with doctor’s handwritten notes, and more.

Then on BioTech Nation, efforts to address two devastating cancers - Late Stage, ARB-7 positive, Prostate Cancer, and AML - Acute Myeloid Leukemia, with special focus on the elderly.

On this week’s Tech Nation, Moira speaks with a group of distinguished professors from Stanford University, UC Berkeley, UCSF and the University of San Francisco. They explain each of the 2015 Nobel Prizes, and why each prize was so deserving.

On this week’s Tech Nation, Moira speaks with NEEL DOSHI & LINDSAY McGREGOR about their book “Primed to Perform” and what motivates and de-motivates you at work. You need to add them together to get your TO-MO, or total motivation.

Then on BioTech Nation, Moira speaks with VINCE AURENTZ, CEO, Hemoshear Therapeutics based in Charlottesville, Virginia. We've talked about their breakthrough technology before. They've set out to develop unprecedented medical therapies.

On this week’s Tech Nation, Moira speaks with SCIENTIFIC AMERICAN columnist MICHAEL SHERMER about his book, “The Moral Arc ... How Science and Reason Lead Humanity Toward Truth, Justice, and Freedom” about how science and reason shape humanity over time.

Then on BioTech Nation, a South African firm makes strides in modelling the human body. Ever since computers have been on the scene, scientists have been trying to model the human body. The problem is: It’s really, really hard to do. DR. RIANN CONRADIE is the Executive Founder of LIFEQ based in Stellenbosch, South Africa.

Then Moira speaks with ROBERT COULL, CEO of SCIODERM, about their new success in treating EB – Epidermolysis Bulossa – a genetic disease described as the worst disease you never heard of.

On this episode of Tech Nation, Moira speaks with MIT professor DAVID MINDELL co-founder of Humatics Corporation about his book “Our Robots, Ourselves: Robotics and the Myths of Autonomy.” He's here to discuss what robots are capable of and what we might want to rethink whether it's driverless cars or predator drones. He's also out to dispel the “persistent misconceptions about robots.”

Then on BioTech Nation, what biotech has been working on to treat rare diseases that primarily effect young boys including hemophilia and Duchene Muscular Dystrophy.

First up is PAUL PERRAULT, CEO of CSL Behring, a 100-year old biotech company founded by the Australian government to fight the Spanish flu, today they focus on rare diseases in plasma and recombinant proteins such as hemophilia.

Then Moira talks to SHANE KOVACS, CFO of PTC Therapeutics about their progress on a treatment for Duchene Muscular Dystrophy.

On this week’s Tech Nation, Moira speaks with GARY SHAPIRO, the long-time President of the Consumer Electronics Association, about what’s happening with technology innovation in the United States and worldwide.

Then on BioTech Nation, it’s all about using viruses and bacteria to deliver treatments for everything from Ebola to rare juvenile diseases from Sanfilippo and Batten disease to Fanconi Anemia.

Our first guest is DR. RIPLEY BALLOU, Head, of Clinical Research and Translational Science at GSK (Glaxo Smith Kline) about what brought us the 2014 Ebola crisis and their race to find a vaccine.

Then we speak with DR. TIM MILLER, President & CEO, Abeona Therapeutics about their work to find gene therapies to treat two rare and deadly diseases classified as lysosomal storage disorders: Sanfilippo type A and type B and juvenile Batten disease. They are also working on another genetic disorder, Fanconi Anemia, using a CRISPR/Cas 9 system to replace defective DNA with the correct sequence.

We finish this episode with DAVID WILLIAMS, Managing Director, Bactevo about their new drug discovery process that uses bacteria. He explains how they are modifying bacteria to create new medicines using new technologies such as DNA sequencing, nano-microfluidic technologies, and artificial intelligence algorithms.

On this week’s Tech Nation, Moira speaks with DAVID PETERSON, a creator of alien languages, including Dothraki for HBO’s Game of Thrones. He’s here with "THE ART OF LANGUAGE INVENTION: From Horse-Lords to Dark Elves, the Words Behind World-Building".

On BioTech Nation, Merck’s Senior V.P. of Global Clinical Development, DR ROY BAYNES, takes us through Merck's wide-ranging cancer program based on their therapeutic Keytruda. This cancer immunotherapy, which enhances the body's own immune response to cancer, has already been approved for Melanoma and Non-Small Cell Lung Cancer and is being tested in dozens of additional cancers.

Then on BioIssue of the Week with David Ewing Duncan, IT meets biotech.

On this week’s Tech Nation, Moira speaks with ADAM TANNER, a fellow at Harvard’s Institute for Quantitative Social Science, and the author of “WHAT STAYS IN VEGAS – The World of Personal Data – Lifeblood of Big Business – and the End of Privacy as We Know It.”

Then on BioTech Nation, TODD SKRINAR, Principal for Life Sciences Advisory and Leader for Big Data Advanced Analytics at Ernst and Young. All those clinical trials needed to prove a drug is safe? Big data and getting bigger.

On this week’s Tech Nation, Moira speaks with JIM ARCHETTO from Gaumard Scientific, based in Miami, Florida. We’ll meet Victoria, Tori, and Trauma Hal – simulated humans used to teach medical professionals.

Then on BioTech Nation, we're talking about gene therapy. It's been promised for years. After a huge scientific effort and enormous financial investment, it's finally here. What is it? How does it work? And why do they use the word "cure"? Moira speaks with JORN ALDAG, CEO of Uniqure whose drug Glybera, created to treat lipoprotein lipase deficiency (LPLD) which causes pancreatitis, is the first ever approved gene therapy. We'll hear about their gene therapy programs in such diverse conditions as hemophilia B and the rare syndrome Sanfilippo as well as countering the effects of the common heart attack.

Then on BioIssue of the Week with David Ewing Duncan, a new report from the Centers of Medicare and Medicaid services on the high cost of healthcare in the US and how that stacks up to expenditures around the world.